A Study of Guselkumab After Switching From Ustekinumab in Participants With Moderate to Severe Psoriasis
Clinical trial NCT07449234 · TERMINATED
Trial details
- NCT number
- NCT07449234
- Sponsor
- Janssen-Cilag Ltd.
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2026-02-09
- Primary completion
- 2026-06-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.